Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hemanth Kumar

Showing results (341-350 of 350) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 350 results.
The Journal of Antimicrobial Chemotherapy|September 23, 2024
Pharmacokinetics of anti-TB drugs in children and adolescents with drug-resistant TB: a multicentre observational study from IndiaHemanth Kumar Agibothu Kupparam, Ira Shah, Padmapriyadarsini Chandrasekaran, et al.
Molecules (Basel, Switzerland)|December 11, 2022
Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT StudiesMahadevamurthy Murali, Hittanahallikoppal Gajendramurthy Gowtham, Natarajamurthy Shilpa, et al.
Plos One|March 3, 2023
In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitorRajesh Mondal, Azger Dusthackeer V N, Palaniyandi Kannan, et al.
BMC Infectious Diseases|July 25, 2024
Efficacy and tolerability of a 4-month ofloxacin-containing regimen compared to a 6-month regimen in the treatment of patients with superficial lymph node tuberculosis: a randomized trialSyed Hissar, Banurekha Velayutham, Manoharan Tamizhselvan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2019
Subtherapeutic Rifampicin Concentration Is Associated With Unfavorable Tuberculosis Treatment OutcomesGeetha Ramachandran, Padmapriyadarshini Chandrasekaran, Sanjay Gaikwad, et al.
Clinical Pharmacokinetics|November 9, 2018
A Systematic Review on the Effect of HIV Infection on the Pharmacokinetics of First-Line Tuberculosis DrugsAlper Daskapan, Lusiana R Idrus, Maarten J Postma, et al.
JAMA Internal Medicine|March 7, 2018
Daily vs Intermittent Antituberculosis Therapy for Pulmonary Tuberculosis in Patients With HIV: A Randomized Clinical TrialNarendran Gopalan, Ramesh Kumar Santhanakrishnan, Alangudi Natarajan Palaniappan, et al.
Scientific Data|November 20, 2020
Diffraction data from aerosolized Coliphage PR772 virus particles imaged with the Linac Coherent Light SourceHaoyuan Li, Reza Nazari, Brian Abbey, et al.
The European Respiratory Journal|November 3, 2022
Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysisFajri Gafar, Roeland E Wasmann, Helen M McIlleron, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 5, 2022
The International Natural Product Sciences Taskforce (INPST) and the power of Twitter networking exemplified through #INPST hashtag analysisRajeev K Singla, Ronita De, Thomas Efferth, et al.
Pageof 35

Showing results (341-350 of 350) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 350 results.
The Journal of Antimicrobial Chemotherapy|September 23, 2024
Pharmacokinetics of anti-TB drugs in children and adolescents with drug-resistant TB: a multicentre observational study from IndiaHemanth Kumar Agibothu Kupparam, Ira Shah, Padmapriyadarsini Chandrasekaran, et al.
Molecules (Basel, Switzerland)|December 11, 2022
Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT StudiesMahadevamurthy Murali, Hittanahallikoppal Gajendramurthy Gowtham, Natarajamurthy Shilpa, et al.
Plos One|March 3, 2023
In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitorRajesh Mondal, Azger Dusthackeer V N, Palaniyandi Kannan, et al.
BMC Infectious Diseases|July 25, 2024
Efficacy and tolerability of a 4-month ofloxacin-containing regimen compared to a 6-month regimen in the treatment of patients with superficial lymph node tuberculosis: a randomized trialSyed Hissar, Banurekha Velayutham, Manoharan Tamizhselvan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2019
Subtherapeutic Rifampicin Concentration Is Associated With Unfavorable Tuberculosis Treatment OutcomesGeetha Ramachandran, Padmapriyadarshini Chandrasekaran, Sanjay Gaikwad, et al.
Clinical Pharmacokinetics|November 9, 2018
A Systematic Review on the Effect of HIV Infection on the Pharmacokinetics of First-Line Tuberculosis DrugsAlper Daskapan, Lusiana R Idrus, Maarten J Postma, et al.
JAMA Internal Medicine|March 7, 2018
Daily vs Intermittent Antituberculosis Therapy for Pulmonary Tuberculosis in Patients With HIV: A Randomized Clinical TrialNarendran Gopalan, Ramesh Kumar Santhanakrishnan, Alangudi Natarajan Palaniappan, et al.
Scientific Data|November 20, 2020
Diffraction data from aerosolized Coliphage PR772 virus particles imaged with the Linac Coherent Light SourceHaoyuan Li, Reza Nazari, Brian Abbey, et al.
The European Respiratory Journal|November 3, 2022
Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysisFajri Gafar, Roeland E Wasmann, Helen M McIlleron, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 5, 2022
The International Natural Product Sciences Taskforce (INPST) and the power of Twitter networking exemplified through #INPST hashtag analysisRajeev K Singla, Ronita De, Thomas Efferth, et al.
Pageof 35